Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Research · May 22, 2018

Islet Transplantation vs Insulin Therapy in Patients With Type 1 Diabetes With Severe Hypoglycemia or Poorly Controlled Glycemia After Kidney Transplantation

The Lancet Diabetes & Endocrinology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Diabetes & Endocrinology
Islet Transplantation Versus Insulin Therapy in Patients With Type 1 Diabetes With Severe Hypoglycaemia or Poorly Controlled Glycaemia After Kidney Transplantation (TRIMECO): A Multicentre, Randomised Controlled Trial
Lancet Diabetes Endocrinol 2018 May 15;[EPub Ahead of Print], S Lablanche, MC Vantyghem, L Kessler, A Wojtusciszyn, S Borot, C Thivolet, S Girerd, D Bosco, JL Bosson, C Colin, R Tetaz, S Logerot, J Kerr-Conte, E Renard, A Penfornis, E Morelon, F Buron, K Skaare, G Grguric, C Camillo-Brault, H Egelhofer, K Benomar, L Badet, T Berney, F Pattou, PY Benhamou

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading